Download MendeleyDesign of Bicyclic Peptide Tandems Mimicking the Homodimeric GDF15 Protein to Inhibit GDF15-GFRaL-RET Complex Cell Signaling.
Noisier, A.F.M., Sandmark, J., Edfeldt, F., Backmark, A., Broddefalk, J., Wandzik, J., Jurva, U., Ek, M., Johansson, C.A., Barlind, L., Gunnarsson, J., Bigalke, J.M., Xue, Y., Frolov, A.I., Kankkonen, C., Roth, R.G., Fritsch, M., Watcham, S., van Rietschoten, K., Mudd, G.E., Harrison, H., Chen, L., Skynner, M.J., Craik, D.J., Chankeshwara, S.V., Lemurell, M.(2025) J Med Chem 68: 21441-21457
- PubMed: 41066664 Search on PubMedSearch on PubMed Central
- DOI: https://doi.org/10.1021/acs.jmedchem.5c01378
- Primary Citation Related Structures:
9HYT, 9Q8K - PubMed Abstract:
The GDF15-GFRaL-RET signaling complex is involved in a broad range of disease states, with agonistic action of GDF15 affecting metabolism and body weight control, while inhibition is indicated in cancer and wasting disorders like cachexia. Here, we describe the discovery of the peptide inhibitors of the GDF15-GFRaL protein-protein interaction to prevent RET-induced signaling using both a structure-guided design and a phage display approach. Phage display provided bicyclic peptide hits with high affinity for GFRaL, and these were dimerized to mimic the bidentate interaction of homodimeric GDF15. Guided by structural data, the monomeric peptides were converted into tandem Bicycle molecules with picomolar affinities, similar to that of the endogenous GDF15 ligand. These dimerized protein mimetics inhibited cell signaling in a functional assay and showed improved pharmacokinetic properties compared with their monomeric counterparts. This is the first example of a homodimeric Bicycle molecule inhibiting receptor complex formation, thereby antagonizing the intracellular signaling response.
- BicycleTx Limited, Portway Building, Granta Park, Cambridge CB21 6GS, U.K.
Organizational Affiliation:
